First Medscape program in collaboration with UCARE-Network: Emerging Therapies for Chronic Spontaneous Urticaria – Understanding How They Work on May 12, 2021, 09:00


Enable JavaScript to view protected content.

Join this expert discussion on the role of IgE in the pathogenesis of CSU and therapies in development. The goal of this activity is to increase understanding of the pathophysiology of chronic spontaneous urticaria (CSU), the role of immunoglobulin E (IgE), and how novel emerging therapies targeting IgE differ from already approved biologic drugs. You can find this activity here: Author: Allen P. Kaplan, MD; Alexander Eggel, PhD - From Medscape Education, April 2021

Post Comment